Skip to main content

Day: December 6, 2024

Avance Gas Holding Ltd: Successfully completed the sixth VLGC delivery to BW LPG

Hamilton, Bermuda. December 6, 2024. Avance Gas Holding Ltd. («Avance Gas» or «Company») (OSE: AGAS) refers to the announcement on August 15, 2024, regarding the sale of its VLGC fleet to BW LPG Ltd (“BW LPG” or “Buyer”) for $1,050 million. Today Avance Gas announces the sixth VLGC delivery, the 2023-built dual-fuel vessel Avance Rigel. In connection with the delivery, 2.141 million shares in BW LPG were issued by the Buyer to Avance Gas. The ship mortgage has been repaid and Avance Gas expects to receive net cash proceeds of $30 million. Following the delivery, Avance Gas owns 9.641 million shares in BW LPG corresponding to a 6.44% ownership share. These consideration shares have a lock-up period of 40 days from the issuance date as previously announced. The six remaining vessels are scheduled for delivery to BW...

Continue reading

HighCo: Shareholding

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF)Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders’ meeting)November 30, 2024 20 455 403 820 194 22 282 341 21 462 147October 31, 2024 20 455 403 818 994 22 281 841 21 462 847September 30, 2024 20 455 403 819 051 22 330 226 21 511 175August 31, 2024 20 455 403 817 851 22 352 336 21 534 485July 31, 2024 20 455 403 818 150 22 352 336 21 534 186June 30, 2024 20 455 403 813 392 22 352 340 21 538 948May 31, 2024 20 455 403 758 861 22 374...

Continue reading

Central Government Borrowing Strategy 2025

Target for domestic bond issuance of kr. 65 billion The target for issuance of government bonds is kr. 65 billion in 2025. The focus will continue to be on issuance in the nominal 2-year and 10-year maturity segments, supplemented with issuance in the central government’s new green bond, the existing 30-year benchmark and inflation-linked government bonds. Opening of 10-year nominal bond and green twin bond A new 10-year nominal government bond maturing in 2035 will be opened via auction on 5 February 2025. The bond will replace 2.25 per cent 2033 as the 10-year benchmark bond. A new green 10-year twin bond will also be opened under an updated Green Bond Framework in the second half of the year. Both government inflation-linked bonds will be included in on-the-run issues To support the liquidity of the central government’s...

Continue reading

ArcelorMittal announces financial calendar for 2025

 ArcelorMittal today announces its financial calendar for 2025. Earnings results announcements:6 February 2025: Q4 and full year 2024 2 May 2025: Q1 2025 31 July 2025: Q2 and half year 2025 6 November 2025: Q3 2025Annual General Meeting of Shareholders:6 May 2025ENDS About ArcelorMittal ArcelorMittal is one of the world’s leading integrated steel and mining companies with a presence in 60 countries and primary steelmaking operations in 15 countries. It is the largest steel producer in Europe, among the largest in the Americas, and has a growing presence in Asia through its joint venture AM/NS India. ArcelorMittal sells its products to a diverse range of customers including the automotive, engineering, construction and machinery industries, and in 2023 generated revenues of $68.3 billion, produced 58.1 million metric tonnes of...

Continue reading

Press Release: Availability of the revised financial statements for Sanofi excluding Opella

Availability of the revised financial statements for Sanofi excluding Opella Paris, France – December 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella (consumer healthcare division) to CD&R, the revised financial statements for Sanofi reflecting the new scope, excluding Opella, are now available on the “Investors” section of sanofi.com in one convenient spreadsheet file. The adjustments to the financial statements reclassify Opella’s business as discontinued operations, in line with the planned transition of Sanofi to a focused, science-driven biopharma company. The revised financial data which were reviewed by Sanofi’s auditors, include details on sales, business net income and reported IFRS financials of Sanofi excluding Opella. From Q4 2024 and until...

Continue reading

TGS Awarded Large 3D Streamer Contract in Southern Atlantic

OSLO, Norway (6 December 2024) – TGS, a leading provider of energy data and intelligence, is pleased to announce award of a large 3D streamer contract in the Southern Atlantic. Acquisition is scheduled to commence in Q4 this year and the contract has a duration of approximately 140 days. Kristian Johansen, CEO of TGS, commented, “We are very pleased to secure this large 3D streamer contract by leveraging our integrated business model. The comprehensive seismic survey is designed for enhanced subsurface imaging in a challenging geological environment. Our Ramform acquisition platform, coupled with our proprietary GeoStreamer and Gemini source technology will secure delivery of high-quality seismic 3D data.” For more information, visit TGS.com or contact: Bård StenbergVP IR & Communication Mobile: +47 992 45 235investor@tgs.com  About...

Continue reading

New Phase IIIB data shows Novartis Fabhalta® improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy

In the Phase IIIB APPULSE-PNH study, oral Fabhalta® (iptacopan) improved the average hemoglobin (Hb) level versus baseline in adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who were switched from anti-C5 therapies (Hb ≥10g/dL following treatment with eculizumab or ravulizumab)1,2PNH is a rare, chronic and serious complement-mediated blood disorder, characterized by hemolysis, anemia, thrombosis and other symptoms, and patients are often treated with anti-C5 therapies3–5Findings from APPULSE-PNH build on the Phase III program showing the efficacy and safety of Fabhalta in adults with PNH1, which is approved in the US, EU, Japan and China6-9Basel, December 6, 2024 – Novartis today announced positive topline results from APPULSE-PNH, a Phase IIIB study evaluating the efficacy and safety of twice-daily oral monotherapy...

Continue reading

LifeWallet Announces Consolidation of All Lines of Business Under the MSP Recovery Brand, While Advancing Initiatives That Align With the Newly Formed Department of Government Efficiency (DOGE)

MIAMI, Dec. 06, 2024 (GLOBE NEWSWIRE) — MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet,” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced the consolidation of all its products, services, and lines of business under a unified company brand: MSP Recovery. The return to its original name reflects the Company’s commitment to the expansion of its core business, innovating technological solutions to achieve secondary payer reimbursement recoveries.  In connection therewith, the Company’s common stock will begin trading on Nasdaq under the ticker symbol “MSPR” on December 9, 2024. This ticker symbol will replace the Company’s current ticker symbol for its common stock, “LIFW.” Additionally, the Company’s publicly traded warrants to purchase...

Continue reading

Himax to Showcase Ultralow Power WiseEye AI Solution at Taipei Building Show

Featuring Revolutionary Smart Door Locks and High-Security Palm Vein Authentication Technology TAINAN, Taiwan, Dec. 06, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq: HIMX) today announced that it will join forces with renowned metal industry companies to showcase its industry leading WiseEye™ ultralow power AI sensing technology for smart door locks and innovative high-security palm vein authentication solution at the 2024 Taipei Building Show. At the event, Himax will collaborate with Duen Yih Metal Industrial Co., Ltd. (DANDY), unveiling the latest JANUS PV smart door lock, part of its JANUS series under the DANDY LOCKS brand. DANDY has over 50 years of excellence in the hardware door lock and security field, specializing in providing innovative access control solutions. The JANUS PV...

Continue reading

Nokia and du deploy first commercial Cloud RAN solution in Middle East and Africa with Red Hat OpenShift

Press ReleaseNokia and du deploy first commercial Cloud RAN solution in Middle East and Africa with Red Hat OpenShiftHighlights du’s technological leadership and commitment to the UAE’s ambitious digital transformation agenda. Nokia’s anyRAN approach offers customers more flexibility, openness, security, and choice in their selection of cloud infrastructure.       The solutions are powered by Red Hat OpenShift.6 December 2024Espoo, Finland – Nokia and du, a leading telecom and digital services provider, today announced that they have deployed the first commercial 5G Cloud RAN solution in the Middle East and Africa region. The partnership highlights du’s hybrid RAN strategy that leverages both purpose-built and cloud-native infrastructures for greater flexibility and scalability. The deployment supports the UAE’s evolving digital requirements...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.